OOIR: Observatory of International Research

Papers

(The H4-Index of Future Medicinal Chemistry is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
The role of descriptors extracted from ligand-target interaction to improve conventional QSAR model performance in the realm of angiogenesis receptor modulation to fight cancer	66
The Connection Between PARP14 and SARS-CoV-2	60
Targeting Tuberculosis – An Interview With Robert Abramovitch	57
Identification of Sulfonamide-Based Butyrylcholinesterase Inhibitors Using Machine Learning	48
Investigations of New N ¹ -Substituted Pyrazoles as Anti-Inflammatory and Analgesic Agents having COX Inhibitory Act	42
Biological and computational evaluation of novel benzofuranyl derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors	38
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity	32
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers	29
In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties	29
Novel Set of Highly Substituted Bis-Pyridines: Synthesis, Molecular Docking and Drug-Resistant Antibacterial Profile	28
α-Glucosidase-targeting 1,2,4-triazole antidiabetic candidates: comparative analysis and future perspectives	26
Therapeutic potential of spirocyclopropyl oxindoles: latest developments in drug discovery	25
Synergistic effect of new pyrimidine derivative with oxacilin against methicillin-resistant Staphylococcus aureus	24
Small molecule dual inhibitors of HDAC6/HSP90 as potential anticancer therapeutics: an overview of design rationality and structure activity relationships	24
Rh(III) and Ru(II) Complexes With Phosphanyl–Alkylamines: Inhibition of DNA Synthesis Induced By Anticancer Rh Complex	23
Basic nitrogen (BaN): a ‘privileged element’ in medicinal chemistry	23
Small-molecule Cathepsin K inhibitors: a medicinal chemistry perspective	22
Recent advances in the design and development of small-molecule MMP-2 inhibitors	22
Advances in AR-Targeting Chimeras: A Case Study of proteolysis-targeting Chimeras From Bench to Bedside	21
Identification of KRAS mutants (G12C, G12D, and G12V) inhibitors	21
New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study	21
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activity	21
Synthesis, antimicrobial evaluation, HPLC-based compound accumulation and docking studies of 2-methoxybenzoyl thioureas	21